Exercise as Medicine for Cancer Survivors: Improvements in Mobility, Endurance, and Fatigue After 12 Weeks

Lead Author Affiliation

Health and Exercise Science

Lead Author Status

Masters Student

Second Author Affiliation

Health and Exercise Science

Second Author Status

Undergraduate - Sophomore

Third Author Affiliation

Health and Exercise Science

Third Author Status

Undergraduate - Sophomore

Fourth Author Affiliation

Health and Exercise Science

Fourth Author Status

Undergraduate - Junior

Fifth Author Affiliation

Health and Exercise Science

Fifth Author Status

Undergraduate - Sophomore

Sixth Author Affiliation

Health and Exercise Science

Sixth Author Status

Undergraduate - Sophomore

Additional Authors

7th author - St. Joseph's Medical Center

8th author - Health and Exercise Science

Faculty Mentor Name

Alexis King

Research or Creativity Area

Health Sciences

Abstract

Introduction: Cancer survivors often experience declines in strength, endurance, and mobility secondary to treatment-related fatigue, deconditioning, and comorbidities1,2. Exercise is recognized as a cornerstone of survivorship care to restore physical function and improve quality of life. This study examined functional outcomes of a 12-week community-based exercise program among adult cancer survivors.

Methods: Twenty cancer survivors (Male 4, Female 16; mean age 66.9±10.4 y; BMI 28.3±6.5 kg/m²) completed a 12-week program. Pre- and post-intervention assessments included 30-s Chair Stand, Timed Up-and-Go (TUG), 6-Minute Walk Test (6MWT), right-hand grip strength, Fatigue Severity Index (FSI), International Physical Activity Questionnaire (IPAQ), and vitals. Paired t-tests evaluated change; effect sizes are Cohen's d. Exploratory analyses examined clinically meaningful change thresholds and dose–response with recorded exercise sessions.

Results: Participants demonstrated statistically significant improvements in multiple functional outcomes: Chair Stand +2.95 reps (10.32→13.26), d=2.41, p<0.001; faster TUG −0.78s (7.21→6.43), d=1.76, p<0.001; 6MWT distance +185 ft (1478→1663 ft), d=1.32, p<0.001; 6MWT % predicted +12.8 points (99.9→112.6%), d=1.28, p<0.001. Self-reported activity increased: IPAQ category +0.50 levels (p=0.004) and IPAQ total +1,096 MET-min·wk⁻¹ (p=0.009). Fatigue decreased: FSI −15.6 points (39.9→24.4), d=1.01, p=0.0002. Grip strength (right) increased +3.25lb (p=0.030). Trends were observed for ↓Borg RPE during 6MWT (−0.55, p=0.150), and small reductions in BP + resting HR ( p>0.12). Clinically meaningful gains were achieved by 30% (6MWT ≥164 ft), 35% (TUG ≥0.8 s faster), and 100% (Chair Stand ≥2 reps). Recorded attendance averaged 29.6±12.6 sessions; the correlation between sessions and 6MWT change was insignificant (r=−0.32, p=0.18).

Conclusion: A community-based exercise program for cancer survivors improved mobility, muscular endurance, walking capacity, and fatigue. The findings reinforce the value of structured, evidence-based exercise in survivorship care. Future work should explore long-term adherence, cancer-type–specific responses, and integration with oncology rehabilitation services.

Purpose

Cancer survivors often experience declines in strength, endurance, and mobility secondary to treatment-related fatigue, deconditioning, and comorbidities1,2. Exercise is recognized as a cornerstone of survivorship care to restore physical function and improve quality of life. This study examined functional outcomes of a 12-week community-based exercise program among adult cancer survivors.

Results

Participants demonstrated statistically significant improvements in multiple functional outcomes: Chair Stand +2.95 reps (10.32→13.26), d=2.41, p<0.001; faster TUG −0.78s (7.21→6.43), d=1.76, p<0.001; 6MWT distance +185 ft (1478→1663 ft), d=1.32, p<0.001; 6MWT % predicted +12.8 points (99.9→112.6%), d=1.28, p<0.001. Self-reported activity increased: IPAQ category +0.50 levels (p=0.004) and IPAQ total +1,096 MET-min·wk⁻¹ (p=0.009). Fatigue decreased: FSI −15.6 points (39.9→24.4), d=1.01, p=0.0002. Grip strength (right) increased +3.25lb (p=0.030). Trends were observed for ↓Borg RPE during 6MWT (−0.55, p=0.150), and small reductions in BP + resting HR ( p>0.12). Clinically meaningful gains were achieved by 30% (6MWT ≥164 ft), 35% (TUG ≥0.8 s faster), and 100% (Chair Stand ≥2 reps). Recorded attendance averaged 29.6±12.6 sessions; the correlation between sessions and 6MWT change was insignificant (r=−0.32, p=0.18).

Significance

A community-based exercise program for cancer survivors improved mobility, muscular endurance, walking capacity, and fatigue. The findings reinforce the value of structured, evidence-based exercise in survivorship care. Future work should explore long-term adherence, cancer-type–specific responses, and integration with oncology rehabilitation services.

This document is currently not available here.

Share

COinS
 

Exercise as Medicine for Cancer Survivors: Improvements in Mobility, Endurance, and Fatigue After 12 Weeks

Introduction: Cancer survivors often experience declines in strength, endurance, and mobility secondary to treatment-related fatigue, deconditioning, and comorbidities1,2. Exercise is recognized as a cornerstone of survivorship care to restore physical function and improve quality of life. This study examined functional outcomes of a 12-week community-based exercise program among adult cancer survivors.

Methods: Twenty cancer survivors (Male 4, Female 16; mean age 66.9±10.4 y; BMI 28.3±6.5 kg/m²) completed a 12-week program. Pre- and post-intervention assessments included 30-s Chair Stand, Timed Up-and-Go (TUG), 6-Minute Walk Test (6MWT), right-hand grip strength, Fatigue Severity Index (FSI), International Physical Activity Questionnaire (IPAQ), and vitals. Paired t-tests evaluated change; effect sizes are Cohen's d. Exploratory analyses examined clinically meaningful change thresholds and dose–response with recorded exercise sessions.

Results: Participants demonstrated statistically significant improvements in multiple functional outcomes: Chair Stand +2.95 reps (10.32→13.26), d=2.41, p<0.001; faster TUG −0.78s (7.21→6.43), d=1.76, p<0.001; 6MWT distance +185 ft (1478→1663 ft), d=1.32, p<0.001; 6MWT % predicted +12.8 points (99.9→112.6%), d=1.28, p<0.001. Self-reported activity increased: IPAQ category +0.50 levels (p=0.004) and IPAQ total +1,096 MET-min·wk⁻¹ (p=0.009). Fatigue decreased: FSI −15.6 points (39.9→24.4), d=1.01, p=0.0002. Grip strength (right) increased +3.25lb (p=0.030). Trends were observed for ↓Borg RPE during 6MWT (−0.55, p=0.150), and small reductions in BP + resting HR ( p>0.12). Clinically meaningful gains were achieved by 30% (6MWT ≥164 ft), 35% (TUG ≥0.8 s faster), and 100% (Chair Stand ≥2 reps). Recorded attendance averaged 29.6±12.6 sessions; the correlation between sessions and 6MWT change was insignificant (r=−0.32, p=0.18).

Conclusion: A community-based exercise program for cancer survivors improved mobility, muscular endurance, walking capacity, and fatigue. The findings reinforce the value of structured, evidence-based exercise in survivorship care. Future work should explore long-term adherence, cancer-type–specific responses, and integration with oncology rehabilitation services.